Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001698262-25-000005 |
|---|---|
| Form Type | 4 |
| Filing Date | Dec 30, 2025 |
| Document Date | Dec 24, 2025 |
| Document | View SEC Filing |
Transactions
3
Total Shares
180,000
Total Value
$3,642,780.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer | Common Stock | โ | Dec 24, 2025 | Exercise/Conversion | 60,000 | $20.61 | $1,236,600.00 | 161,443 | Direct | โ | View Details | |
Chief Research Officer | Common Stock | โ | Dec 24, 2025 | Sale | 60,000 | $40.10 | $2,406,180.00 | 101,443 | Direct | โ | View Details | |
Chief Research Officer | Employee stock option (right to buy) | Derivative | Dec 24, 2025 | Exercise/Conversion | 60,000 | $0.00 | $0.00 | 0 | Direct | โ | View Details |